期刊文献+

阿托伐他汀对Aβ_(1-42)诱导的大鼠AD模型保护作用及其机制研究 被引量:9

Protective effects of atorvastatin on Aβ_(1- 42)-induced AD model rats and its mechanism
在线阅读 下载PDF
导出
摘要 目的观察阿托伐他汀(atorvastatin,Ato)对Aβ1-42诱导的AD大鼠学习记忆功能、炎症因子释放以及突触素(synaptophysin,SYP)和磷酸化JNK(p-JNK)蛋白表达的影响及机制。方法选用健康SD大鼠60只,随机分为4组:正常对照组、Aβ1-42组、Ato+Aβ1-42组、Ato组,每组15只,采用侧脑室注射给药。应用酶联免疫吸附(ELISA)法检测AD大鼠海马组织上清液内白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、白细胞介素-4(IL-4)含量;Morris水迷宫实验观察AD大鼠的行为学变化;Western blot法检测AD大鼠海马突触素(synaptophysin,SYP)、pJNK蛋白表达水平。结果与正常对照组相比,脑室注射Aβ1-42后大鼠出现明显的学习记忆障碍,即逃避潜伏期明显延长,原平台象限游泳时间占总游泳时间百分比明显降低(P<0.01);海马组织上清液中IL-1β、IL-6、TNF-α的含量明显增加(P<0.01);SYP蛋白表达量明显减少(P<0.01);pJNK蛋白表达水平明显增加(P<0.01)。Ato给药后可明显对抗Aβ1-42引起的大鼠学习记忆障碍,抑制Aβ1-42引起的IL-1β、IL-6、TNF-α含量(P<0.05,P<0.01)、SYP蛋白表达增加(P<0.01)及p-JNK蛋白表达水平明显减少(P<0.05)。结论 Ato能够明显改善Aβ1-42引起的AD大鼠学习记忆障碍、炎症细胞因子释放增加及SYP蛋白表达降低,这种保护作用可能与Ato抑制JNK信号转导通路的激活有关。 Aim To investigate the effect of atorvasta-tin (Ato) on Aβ1_42 induced spatial learning and memory ability in AD rats and the responsible mecha-nisms. Methods Sixty healthy male Sprague-Dawley (SD) rats were randomly divided into four groups : con-trol group, Aβ1_42 group, and Ato + Aβ1_42 group, and Ato group, n = 15. The intracerebroventricular in-jection of medication was adopted. Enzyme-linked im-munosorbent assay (ELISA) was used to examine the content of interleukin-1 [3 ( IL-1β ), and interleukin-6 (IL-6) and tumor necrosis factor-(TNF-α) , and in-terleukin-4 (IL-4) in rat hippocampus supernatant. Morris water maze experiment was applied to observe the change of behavior in AD rats. The protein expres- sions of SYP and p-JNK were determined by Western blot in rat hippoeampus. Results Injection after A[31-42 single ventricles model, compared with normal control group, the escape latency increased and per- centage of time spent in the target quadrant was low-ered (P 〈0.01 ) , the expression of hippocampus SYPsignificantly decreased (P 〈 0.01 ) and IL-1 [3, IL-6, TNF-α levels and the expression of p-JNK increased (P 〈0.01 ) in the hippocampus of AD rats. After in- traventricular injection of Ato, compared with Aβ1_42 group, Ato + Aβ1_42 significantly shortened escape la- tency, increased the percentage of time spent in the target quadrant (P 〈0.05, P 〈0. 01 ) and the expres- sion of SYP (P 〈0.01), and IL-I[3, IL-6, TNF-o~ levels and the expression of p-JNK significantly de- creased (P 〈 0.01 ) in the hippocampus of AD rats. Conclusions Ato can significantly improve the spatial learning and memory impairment of A[31-42 induced AD rats, increase the release of inflammatory cytokines and decrease SYP protein expression. These protective effects may be related to Ato inhibiting the activation of JNK signal transduction pathway.
出处 《中国药理学通报》 CAS CSCD 北大核心 2014年第2期270-274,共5页 Chinese Pharmacological Bulletin
基金 辽宁医学院校长基金-奥鸿博泽研究生科研创新基金(No 2012005) 辽宁医学院青年科技启动基金项目(No Y2012Z020)
关键词 阿托伐他汀 8淀粉样蛋白 炎症因子 Morris水迷 宫突触素 信号转导通路 atorvastatin amyloid-[3 protein inflam-matory cytokines Morris water maze synaptophysin signal transduction pathway
  • 相关文献

参考文献6

二级参考文献91

  • 1闵嵘,秦川,赵志炜,姬志娟,刘梦霞,盛树力.APP17肽对APP转基因小鼠突触相关蛋白表达的影响[J].中国药理学通报,2006,22(6):710-714. 被引量:8
  • 2刘卓,金英,姚素艳,郑德宇,郭晓丽,齐志敏.知母皂苷对淀粉样β蛋白片段25~35引起的神经细胞凋亡的保护作用(英文)[J].中国药理学与毒理学杂志,2006,20(4):295-304. 被引量:23
  • 3Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule- associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986; 83: 4913-4917.
  • 4Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 5646-5650.
  • 5Mandelkow EM, Biemat J, Drewes G, Gustke N, Trinczek B, Mandelkow E. Tau domains, phosphorylation, and interactions with microtubules. Neurobiol Aging 1995; 16: 355-362.
  • 6Alonso AC, Grundke-Iqbal I, Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 1996; 2: 783-787.
  • 7Churcher I. Tau therapeutic strategies for the treatment of Alzheimer's disease. Curr Top Med Chem 2006; 6: 579-595.
  • 8Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, Titani K, Ihara Y. Hyperphos- phorylation of tau in PHF. Neurobiol Aging 1995; 16:365-380.
  • 9Liu SJ, Wang JZ. Alzheimer-like tau phosphorylation induced in vivo by wortmannin and its attenuation by melatonin. Acta Pharmacol Sin 2002; 23: 183-187.
  • 10Pei JJ, Braak H, An WL, Wlnblad B, Cowbum RF, Iqbal K, Grundke- Iqbal I. Up-regulation of mitogen-activated protein kinases ERK 1/ 2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Mol Brain Res 2002; 109: 45-55.

共引文献40

同被引文献97

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部